Cameron Gray's Net Worth
$370 Thousand
Who is Cameron Gray?
Cameron Gray does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Provention Bio, Inc., Cue Biopharma, Inc., and ENDEAVOR IP, INC..
SEC CIK
Cameron Gray's CIK is 0001590583
Past Insider Trading and Trends
2018 was Cameron Gray's most active year for acquiring shares with 4 total transactions. Cameron Gray's most active month to acquire stocks was the month of December. 2022 was Cameron Gray's most active year for disposing of shares, totalling 2 transactions. Cameron Gray's most active month to dispose stocks was the month of May. 2022 saw Cameron Gray paying a total of $164,999.70 for 71,111 shares, this is the most they've acquired in one year. In 2022 Cameron Gray cashed out on 112,673 shares for a total of $164,998.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Provention Bio, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cue Biopharma, Inc. (CUE) Snapshot price: $0.7586
InvestorCameron Gray owns 687,049 units of Common Stock which is worth $521,195.37. In the year 2017 Cameron Gray acquired a total of 71,111 shares in Cue Biopharma, Inc. at a cost of $316,499.70, Cameron also disposed a total of 51,562 shares of Cue Biopharma, Inc. equalling to $164,998.40.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.41% | 9.55K |
$2.95 | $1.30 | 687.05K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
| +1.50% | 10K |
$15.15 | $151,500.00 | 677.5K |
Sep 29 - Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ENDEAVOR IP, INC. No price found
CEO, CFO, Secretary, Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||